耐火性伯基特淋巴瘤:诊断和干预策略
Francesco Malfona1, Anna Maria Testi1, Sabina Chiaretti1
1Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
Blood and lymphatic cancer : targets and therapy
|March 21, 2024
概括
耐火性伯基特淋巴瘤的预后很差,尽管前线治疗. 目前的数据有限,但新的向药物显示出治疗这种具有挑战性的白血病的前景.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 耐火性伯基特淋巴瘤是一个重大的治疗挑战,特别是在儿科病例中,患者的治疗结果不佳.
- 存活率较低,延长存活率主要观察到接受血造干细胞移植的患者.
- 来自小型异质患者系列的有限数据阻碍了对耐火性疾病的最终治疗结论.
研究的目的:
- 审查目前对耐火性伯基特淋巴瘤/白血病的治疗结果.
- 评估标准疗法和造血干细胞移植的疗效.
- 探索Burkitt淋巴瘤/白血病细胞生物学研究中出现的新型向药物.
主要方法:
- 对耐火性伯基特淋巴瘤/白血病报告结果的文献综述.
- 对标准治疗和血造干细胞移植的数据进行分析.
- 对新向疗法的正在进行的临床试验进行审查.
主要成果:
- 标准治疗和造血干细胞移植在耐火性伯基特淋巴瘤中提供了有限的生存益处.
- 由于患者和治疗异质性,现有的数据不足以建立黄金标准的救援治疗.
- 新的向药物正在调查中,提供了改善结果的潜力.
结论:
- 耐火性伯基特淋巴瘤仍然是一个难以治疗的恶性瘤,预后不佳.
- 造血干细胞移植可能会改善存活率,但并不能普遍治愈.
- 新兴的向疗法为未来的治疗策略提供了一个有希望的途径.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
09:10An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
Published on: November 15, 2024
400
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
